AKT1 and neoplasm: In addition, we also observed by immunohistochemical analysis a reduction in the phosphorylation of AKT in the tumor nodules of mice treated with AAVApoLinkerP144, reflecting that the fusion protein was able to block a non-canonical TGF-β signaling pathway in vivo (Figure S5 in File S1).